Epoxide Hydrolases: a Biocatalytic Technology Platform for the Production of Chiral Pharmaceutical Intermediates Oxyrane's epoxide hydrolase technology has matured into a robust and versatile platform for the scaleable and cost-effective manufacturing of enantiopure pharmaceutical chemicals which can be seamlessly integrated into existing chemical manufacturing plants Adriana L. Botes and Robin K. Mitra, Oxyrane UK Limited (January 2007)
|